|
시장보고서
상품코드
2040779
지속 가능한 의약품 포장 시장 규모, 점유율과 동향 분석 보고서 : 소재별, 제품별, 프로세스별, 지역별, 부문 예측(2026-2033년)Sustainable Pharmaceutical Packaging Market Size, Share & Trends Analysis Report By Material (Plastic, Paper & Paperboard, Glass, Metal), By Product (Primary, Secondary, Tertiary), By Process, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
지속 가능한 의약품 포장 시장 요약
세계의 지속 가능한 의약품 포장 시장 규모는 2025년에 1,129억 달러로 평가되었고, 2033년까지 2,856억 달러에 이를 것으로 예상되고 있어 2026-2033년 CAGR 12.1%를 보일 전망입니다.
이 산업은 환경 문제에 대한 인식 증가와 규제 압력 등을 반영하는 몇 가지 주요 요인에 의해 주도되고 있습니다.
주요 촉진요인 중 하나는 제약 산업을 포함한 모든 산업에서 플라스틱 폐기물 및 탄소 발자국 감소에 대한 관심이 높아지고 있다는 점입니다. 이에 따라 생분해성 플라스틱, 재생지, 식물성 대체 소재 등 친환경 포장재에 대한 수요가 급증하고 있습니다.
또한, 규제 변화와 정부의 이니셔티브도 지속 가능한 의약품 포장의 트렌드를 형성하는 데 중요한 역할을 하고 있습니다. 많은 국가에서 일회용 플라스틱에 대한 규제를 강화하고 재활용 가능한 재료의 사용을 장려하고 있습니다. 예를 들어, 유럽연합(EU)의 '순환 경제 행동 계획'은 2030년까지 모든 포장을 재사용 또는 재활용할 수 있도록 하는 것을 목표로 하고 있으며, 제약회사에 포장 디자인 혁신을 촉구하고 있습니다. 이에 따라 재활용이 용이한 단일 소재의 블리스터 팩과 같은 솔루션이 개발되고 있습니다.
소비자의 의식과 선호도 또한 지속 가능한 의약품 포장 산업의 중요한 촉진요인 중 하나입니다. 환자들의 환경에 대한 인식이 높아짐에 따라 지속 가능한 재료로 포장된 의약품에 대한 수요가 증가하고 있습니다. 이러한 추세에 따라 기업들은 보다 친환경적인 포장을 채택할 뿐만 아니라, 소비자들에게 지속가능성에 대한 기업의 노력을 전달할 필요가 있습니다.
업계 선두 기업들은 경쟁력을 강화하고 시장 기회를 최대한 활용하기 위해 여러 가지 전략적 노력을 기울이고 있습니다. 이러한 전략에는 신제품 출시, 인수합병, 파트너십 및 제휴, 새로운 지역으로의 사업 확장 등이 포함됩니다. 예를 들어, 2024년 2월, 사노피 소비자 건강관리(CHC)는 PA 컨설팅과 펄팩이 설립한 '블리스터 팩 콜렉티브'에 참여하여 의약품 포장의 플라스틱 폐기물을 줄이기 위해 재활용 가능한 섬유 기반 블리스터 팩을 개발하기 위해 노력해왔습니다. 개발하였습니다. 이 사업은 의료용 포장재에 연간 10만 톤이 사용되는 플라스틱의 한 원인인 PVC 등 문제가 되는 플라스틱을 기존 소재 대비 CO2 배출량을 80% 줄일 수 있는 PulPac의 '드라이몰드 파이버(Dry Molded Fiber)' 기술로 대체하는 것을 목표로 하고 있습니다. 대체하는 것을 목표로 하고 있습니다. 따라서 이번 전략적 결정은 포장 제품의 지속가능성을 높이고 친환경 포장 솔루션을 향한 업계 전반의 변화를 촉진하기 위한 것입니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 지속 가능한 의약품 포장 시장 : 변수, 동향, 범위
제4장 지속 가능한 의약품 포장 시장 : 소재별 추정·동향 분석
제5장 지속 가능한 의약품 포장 시장 : 제품별 추정·동향 분석
제6장 지속 가능한 의약품 포장 시장 : 프로세스별 추정·동향 분석
제7장 지속 가능한 의약품 포장 시장 : 지역별 추정·동향 분석
제8장 경쟁 구도
제9장 기업 리스트·개요
제10장 전략적 제안/애널리스트의 견해
LSH 26.06.04Sustainable Pharmaceutical Packaging Market Summary
The global sustainable pharmaceutical packaging market size was valued at USD 112.9 billion in 2025 and is expected to reach USD 285.6 billion by 2033, expanding at a CAGR of 12.1% from 2026 to 2033. The industry is driven by several key factors, reflecting a growing awareness of environmental issues and regulatory pressures.
One of the primary drivers is the increasing focus on reducing plastic waste and carbon footprint across industries, including pharmaceuticals. This has led to a surge in demand for eco-friendly packaging materials such as biodegradable plastics, recycled paper, and plant-based alternatives.
In addition, regulatory changes and government initiatives are playing a crucial role in shaping the sustainable pharmaceutical packaging landscape. Many countries have implemented stricter regulations on single-use plastics and are encouraging the use of recyclable materials. For instance, the European Union's Circular Economy Action Plan aims to make all packaging reusable or recyclable by 2030, pushing pharmaceutical companies to innovate in their packaging designs. This has led to the development of solutions like blister packs made from mono-materials that are easier to recycle.
Consumer awareness and preferences are another significant driving factor for the sustainable pharmaceutical packaging industry. As patients become more environmentally conscious, there's a growing demand for pharmaceuticals packaged in sustainable materials. This trend is pushing companies to not only adopt greener packaging but also to communicate their sustainability efforts to consumers.
Major companies in the industry are undertaking multiple strategic initiatives to enhance their competitive position and capitalize on market opportunities. These strategies include launching new products, engaging in mergers and acquisitions, forming partnerships & collaborations, and expanding into new geographic regions. For instance, in February 2024, Sanofi Consumer Healthcare joined the Blister Pack Collective, formed by PA Consulting and PulPac, to develop recyclable fibre-based blister packs aimed at reducing plastic waste in pharmaceutical packaging. The initiative seeks to replace problematic plastics like PVC, which contribute to the 100,000 tonnes of plastic used annually in medical packaging, with PulPac's Dry Molded Fiber technology, which boasts an 80% lower CO2 footprint compared to traditional materials. Hence, this strategic decision was intended to enhance the sustainability of its packaging product and inspire industry-wide changes towards environmentally friendly packaging solutions.
Global Sustainable Pharmaceutical Packaging Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global sustainable pharmaceutical packaging market report on the basis of material, product, process, and region:
- Material Outlook (Revenue, USD Million, 2021 - 2033)
- Plastics
- Paper & Paperboard
- Glass
- Metal
- Others
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Primary
- Plastic Bottles
- Caps & Closures
- Parenteral Containers
- Blister Packs
- Prefillable Inhalers
- Pouches
- Medication Tubes
- Others
- Secondary
- Prescription Containers
- Pharmaceutical Packaging Accessories
- Tertiary
- Process Outlook (Revenue, USD Million, 2021 - 2033)
- Recyclable
- Reusable
- Biodegradable
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Central & South America
- Brazil
- Argentina
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Materials & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
- 1.7. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Outlook, 2025 (USD Million)
- 2.2. Segmental Outlook
- 2.3. Competitive Landscape Snapshot
Chapter 3. Sustainable Pharmaceutical Packaging Market Variables, Trends, and Scope
- 3.1. Market Lineage Outlook
- 3.2. Penetration and Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Raw Material Trends
- 3.3.2. Manufacturing Trends
- 3.3.3. Profit Margin Analysis
- 3.3.4. Sales Channel Analysis
- 3.4. Regulatory Framework
- 3.4.1. Product Classification Codes
- 3.4.2. Standards & Safety
- 3.5. Technology Timeline & Analysis
- 3.6. Market Dynamics
- 3.6.1. Market Driver Analysis
- 3.6.2. Market Restraint Analysis
- 3.6.3. Market Challenges Analysis
- 3.6.4. Market Opportunity Analysis
- 3.7. Business Environment Analysis
- 3.7.1. Industry Analysis - Porter's
- 3.7.2. PESTEL Analysis
- 3.8. Latest Trends & Technologies in Sustainable Pharmaceutical Packaging Market
Chapter 4. Sustainable Pharmaceutical Packaging Market: Material Estimates & Trend Analysis
- 4.1. Definition & Scope
- 4.2. Material Movement Analysis & Market Share, 2025 & 2033
- 4.3. Plastics
- 4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.4. Paper & Paperboard
- 4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.5. Glass
- 4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.6. Metal
- 4.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.7. Others
- 4.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. Sustainable Pharmaceutical Packaging Market: Product Estimates & Trend Analysis
- 5.1. Definition & Scope
- 5.2. Product Movement Analysis & Market Share, 2025 & 2033
- 5.3. Primary
- 5.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.3.2. Plastic Bottles
- 5.3.3. Caps & Closures
- 5.3.4. Parenteral Containers
- 5.3.5. Blister Packs
- 5.3.6. Prefillable Inhalers
- 5.3.7. Pouches
- 5.3.8. Medication Tubes
- 5.3.9. Others
- 5.4. Secondary
- 5.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.4.2. Prescription Containers
- 5.4.3. Pharmaceutical Packaging Accessories
- 5.5. Tertiary
- 5.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. Sustainable Pharmaceutical Packaging Market: Process Estimates & Trend Analysis
- 6.1. Definition & Scope
- 6.2. Process Movement Analysis & Market Share, 2025 & 2033
- 6.3. Recyclable
- 6.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.4. Reusable
- 6.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.5. Biodegradable
- 6.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 7. Sustainable Pharmaceutical Packaging Market: Regional Estimates & Trend Analysis
- 7.1. Key Takeaways
- 7.2. Regional Movement Analysis & Market Share, 2025 & 2033
- 7.3. North America
- 7.3.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.3.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.3.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.3.5. U.S.
- 7.3.5.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.5.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.3.5.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.3.5.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.3.6. Canada
- 7.3.6.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.6.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.3.6.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.3.6.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.3.7. Mexico
- 7.3.7.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.7.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.3.7.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.3.7.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.4. Europe
- 7.4.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.4.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.4.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.4.5. Germany
- 7.4.5.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.5.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.4.5.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.4.5.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.4.6. U.K.
- 7.4.6.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.6.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.4.6.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.4.6.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.4.7. France
- 7.4.7.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.7.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.4.7.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.4.7.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.4.8. Italy
- 7.4.8.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.8.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.4.8.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.4.8.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.4.9. Spain
- 7.4.9.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.9.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.4.9.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.4.9.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.5.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.5.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.5.5. China
- 7.5.5.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.5.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.5.5.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.5.5.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.5.6. India
- 7.5.6.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.6.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.5.6.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.5.6.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.5.7. Japan
- 7.5.7.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.7.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.5.7.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.5.7.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.5.8. South Korea
- 7.5.8.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.8.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.5.8.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.5.8.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.5.9. Australia
- 7.5.9.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.9.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.5.9.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.5.9.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.6. Central & South America
- 7.6.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.6.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.6.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.6.5. Brazil
- 7.6.5.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.5.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.6.5.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.6.5.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.6.6. Argentina
- 7.6.6.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.6.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.6.6.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.6.6.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.7. Middle East & Africa
- 7.7.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.7.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.7.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.7.5. Saudi Arabia
- 7.7.5.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.5.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.7.5.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.7.5.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.7.6. UAE
- 7.7.6.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.6.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.7.6.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.7.6.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
- 7.7.7. South Africa
- 7.7.7.1. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.7.2. market estimates and forecasts, by material, 2021 - 2033 (USD Million)
- 7.7.7.3. market estimates and forecasts, by product, 2021 - 2033 (USD Million)
- 7.7.7.4. market estimates and forecasts, by process, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Key Players & Recent Developments & Their Impact on the Industry
- 8.2. Vendor Landscape
- 8.2.1. Key Company/Competition Categorization
- 8.2.2. List of key Raw Material Distributors and Channel Partners
- 8.3. Company Market Position Analysis, 2025
- 8.4. Company Heat Map Analysis
- 8.5. Competitive Dashboard Analysis
- 8.6. Strategy Mapping
- 8.6.1. Collaboration/ Partnerships/ Agreements
- 8.6.2. New Product launches
- 8.6.3. Mergers & Acquisitions
- 8.6.4. Others
Chapter 9. Company Listing / Profiles
- 9.1. Amcor plc
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Strategic Initiatives
- 9.2. Berry Global Inc.
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Strategic Initiatives
- 9.3. Sonoco Products Company
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Strategic Initiatives
- 9.4. WestRock Company
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Strategic Initiatives
- 9.5. CCL Healthcare
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Strategic Initiatives
- 9.6. SGD Pharma
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Strategic Initiatives
- 9.7. OLIVER
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Strategic Initiatives
- 9.8. Gerresheimer AG
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Strategic Initiatives
- 9.9. West Pharmaceutical Services, Inc.
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Strategic Initiatives
- 9.10. Nottingham Spirk
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Strategic Initiatives
- 9.11. Crown Packaging Corp.
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Strategic Initiatives
- 9.12. Nipro Europe Group Companies
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Strategic Initiatives
- 9.13. Origin Pharma Packaging
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Strategic Initiatives
- 9.14. Syntegon Technology GmbH
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Strategic Initiatives
- 9.15. Bormioli Pharma S.p.A.
- 9.15.1. Company Overview
- 9.15.2. Financial Performance
- 9.15.3. Product Benchmarking
- 9.15.4. Strategic Initiatives
